Independent support for a function for RNF5 in recruiting RBBP4 to transcriptional regulatory complexes comes from our finding that RNF5/RBBP4 abundance governs the sensitivity of AML cells to HDAC inhibitors. This evidence concerns the gene HDAC9 and acute myeloid leukemia.